2020
DOI: 10.1002/alz.043397
|View full text |Cite
|
Sign up to set email alerts
|

TRPML1: A novel therapeutic target to remediate endolysosomal pathology in Alzheimer’s disease

Abstract: Background TRPML1 (transient receptor potential channel mucolipin 1) is an essential endosomal‐lysosomal Ca2+ channel whose loss of function can cause neurodegeneration. Defects in the endosomal‐autophagic‐lysosomal (EAL) are a primary feature of Alzheimer’s disease (AD) pathogenesis, and many late‐onset AD (LOAD) risk genes, including APOE4, functionally converge on the EAL system, although the underlying mechanisms remain unclear. Dysfunctional TRPML1 activity has been reported in genetic models of AD involv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…It was found to be downregulated in APP/PS1 transgenic mice, while the overexpression of this channel was associated with rescuing memory and recognition impairment and with attenuated neuronal apoptosis in APP/PS1 transgenic mice [321]. The activation of these channels in postmortem late-onset AD (LOAD) hippocampal neurons using the agonist ML-SA1 was shown to restore endolysosomal calcium pools to normal levels, decrease endolysosomal swelling, and increase the levels of non-pathogenic fragments of APP [322]. Despite these promising results, few studies have examined TRPML1 regulation in AD models.…”
Section: Trp Channel Mucolipinmentioning
confidence: 99%
“…It was found to be downregulated in APP/PS1 transgenic mice, while the overexpression of this channel was associated with rescuing memory and recognition impairment and with attenuated neuronal apoptosis in APP/PS1 transgenic mice [321]. The activation of these channels in postmortem late-onset AD (LOAD) hippocampal neurons using the agonist ML-SA1 was shown to restore endolysosomal calcium pools to normal levels, decrease endolysosomal swelling, and increase the levels of non-pathogenic fragments of APP [322]. Despite these promising results, few studies have examined TRPML1 regulation in AD models.…”
Section: Trp Channel Mucolipinmentioning
confidence: 99%